For patients with myocardial infarction (MI), early oral combination lipid-lowering therapy (LLT) is beneficial.

China: A recent study published in Scientific Reports has highlighted the significant relationship between the ...

Specialists are debating the best approach in cardiogenic shock after a new analysis of data comparing Impella with ...

Advanced CKD was linked to a higher likelihood of both fatal and non-fatal adverse outcomes after acute myocardial infarction treatment. Patients with advanced chronic kidney disease (ACKD) with acute ...

A Swedish study shows that the risk for cardiovascular diseases is elevated in patients with chronic hypoparathyroidism, ...

A new study reveals that heart attack survivors could greatly reduce their risk of a second event by starting combination ...

Compared with the use of other migraine medications, use of erenumab did not increase cardiovascular or cerebrovascular risks.

Despite substantial advancements in the management of cardiogenic shock, mortality rates remain greater than 40%. Trials have ...

The following is a summary of "Sex differences in outcomes in patients with acute myocardial infarction," published in the ...